Infinity Pharmaceuticals, Inc.

VANGUARD GROUP INC INFIQ

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

3,981,857

Value ($000)

838

Weight

0.0%

2013 Q4 - 2023 Q2 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	838	0.0%	3,981,857	6/30/2023
2023 Q1	7/14/2023	639	0.0%	3,994,874	3/31/2023
2022 Q4	2/10/2023	2,949	0.0%	5,313,679	12/31/2022
2022 Q3	11/14/2022	6,321	0.0%	5,311,689	9/30/2022
2022 Q2	8/12/2022	3,332	0.0%	5,270,916	6/30/2022
2022 Q1	5/13/2022	6,595	0.0%	5,785,288	3/31/2022
2021 Q4	2/14/2022	13,013	0.0%	5,783,433	12/31/2021
2021 Q3	11/12/2021	19,009	0.0%	5,558,159	9/30/2021
2021 Q2	8/13/2021	13,105	0.0%	4,382,805	6/30/2021
2021 Q1	5/14/2021	11,447	0.0%	3,544,054	3/31/2021
2020 Q4	2/12/2021	4,939	0.0%	2,329,941	12/31/2020
2020 Q3	11/16/2020	2,706	0.0%	2,312,993	9/30/2020
2020 Q2	8/14/2020	2,093	0.0%	2,312,993	6/30/2020
2020 Q1	5/15/2020	1,938	0.0%	2,312,993	3/31/2020
2019 Q4	2/14/2020	2,220	0.0%	2,312,993	12/31/2019
2014 Q2	8/11/2014	34,465	0.0%	2,705,287	6/30/2014
2014 Q1	5/13/2014	31,604	0.0%	2,657,999	3/31/2014
2013 Q4	2/12/2014	35,052	0.0%	2,538,194	12/31/2013